Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Joliet › NPI 1891876371
Physician

Dipasquale, Anthony

Dipasquale, Anthony was paid $468K by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.

33Billing provider infoDIPASQUALE, ANTHONY
JOLIET, IL 60435
33aNPI1891876371assigned 10/18/2006
28Total paid$468K
24GClaims17,662
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatric Adolescent Medicine Physician providers in Illinois

Rank by total paid#8 of 44
Median peer was paid$65K
This provider vs. median7.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,415$30K
20191,930$42K
20201,951$38K
20212,961$96K
20223,074$85K
20233,282$84K
2024incomplete3,049$93K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 52% 4,949 4,264 $246K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 9.3% 306 259 $44K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 8.7% 611 448 $41K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 7.2% 455 337 $34K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4.7% 317 199 $22K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.7% 778 623 $12K
87631 2.5% 109 103 $12K
36416 1.4% 1,671 1,282 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 124 118 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.4% 251 209 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.2% 126 119 $6K
86580 1.1% 995 710 $5K
24 more codes
90677 1.0% 68 $5K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 58 $4K
85018 <1% 1,731 $4K
81002 <1% 1,197 $3K
83655 <1% 195 $2K
80061 Lipid panel <1% 250 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 53 $1K
96127 <1% 76 $1K
99051 <1% 320 $960.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 12 $790.46
90670 <1% 60 $680.20
90716 <1% 40 $668.40
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 45 $657.00
90633 <1% 37 $618.27
90686 <1% 39 $489.07
90700 <1% 29 $484.59
90707 <1% 20 $334.20
90651 <1% 12 $200.52
90698 <1% 13 $163.28
82465 <1% 18 $76.32
1036F 0% 28 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 0% 1,832 $0.00
90461 0% 776 $0.00
99072 0% 61 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.